A Review of 20 Years' Experience with the Novopen® Family of Insulin Injection Devices

Rex, Jørn; Jensen, Klaus H.; Lawton, Simon A.
July 2006
Clinical Drug Investigation;2006, Vol. 26 Issue 7, p367
Academic Journal
NovoPen, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen family of injection devices in diabetes management. A search for NovoPen publications from 1985 onwards was conducted in the following databases: MEDLINE/PubMed, Cochrane Database of Systematic Reviews, American College of Physicians Journal Club, Database of Abstract Reviews and Effects, and Cochrane Controlled Trials Register. Publications were examined and underwent a selection process to identify studies of NovoPen devices (NovoPen [1], NovoPen 2, NovoPen 1.5 and NovoPen 3) in the diabetes/insulin therapy area that contained evidence of the effects of NovoPen in a variety of categories. Of the studies identified, most showed that insulin regimens using the NovoPen family of devices are at least as effective (and in some cases superior) in maintaining glycaemic control and are as safe (in terms of hypoglycaemia) as conventional insulin regimens employing syringes. The published evidence identified also showed that insulin administration via NovoPen devices was for most patients easier, more convenient and quicker than with conventional syringes and that most patients preferred the various NovoPen devices over syringes. There was also some evidence that the use of discreet devices, like those of the NovoPen family, facilitates adherence to intensive insulin therapy regimens, helps to improve lifestyle flexibility and reduces injection pain compared with conventional syringe-based regimens. Together these benefits of NovoPen devices are considered likely to improve both patients’ quality of life and compliance with therapy.In conclusion, a large body of published evidence accumulated over the past two decades testifies to the patient-related benefits of the NovoPen family of insulin injection devices in the treatment of diabetes.


Related Articles

  • Things You Need to Know to Choose the Right Syringe.  // Diabetes Health;Nov2006, Vol. 15 Issue 11, p35 

    The article identifies three factors that people with diabetes should consider when choosing the right insulin syringe. The first factor to consider in choosing the right insulin syringe is the syringe size. Using an insulin syringe with an appropriate size draws up an accurate insulin dose. The...

  • Enhanced Absorption of Insulin Aspart as the Result of a Dispersed Injection Strategy Tested in a Randomized Trial in Type 1 Diabetic Patients. MADER, JULIA K.; BIRNGRUBER, THOMAS; KORSATKO, STEFAN; DELLER, SIGRID; KÖHLER, GERD; BOYSEN, SUSANNE; AUGUSTIN, THOMAS; MAUTNER, SELMA I.; SINNER, FRANK; PIEBER, THOMAS R. // Diabetes Care;Apr20123, Vol. 36 Issue 4, p780 

    OBJECTIVE--We investigated the impact of two different injection strategies on the pharmacokinetics and pharmacodynamics of insulin aspart in vivo in an open-label, two-period crossover study and verified changes in the surface-to-volume ratio ex vivo. RESEARCH DESIGN AND METHODS--Before the...

  • Insulin Injection.  // AHFS Consumer Medication Information;Jul2020, p1 

    Insulin injection is used to control blood sugar in people who have type 1 diabetes (condition in which the body does not make insulin and therefore cannot control the amount of sugar in the blood) or in people who have type 2 diabetes (condition in which the blood sugar is too high because the...

  • Overall satisfaction increased more with inhaled insulin than with subcutaneous insulin in type 1 diabetes. Bilous, Rudy // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p101 

    Comments on a study which investigated treatment satisfaction with inhaled insulin in patients with type 1 diabetes. Outcome measures; Comparison of the effects of inhaled insulin and subcutaenous insulin injection on patients with type 1 diabetes mellitus.

  • Inhaled insulin shown effective in treatment of diabetes. ROSE, VERNA L.; SKYLER, JAY A. // American Family Physician;10/15/1998, Vol. 58 Issue 6, p1400 

    Presents information on a study which shows that inhaled insulin is effective in the treatment of diabetes. Methodology of the study; Results of the study.

  • Diabetes: How to Use Insulin.  // American Family Physician;8/1/1999, Vol. 60 Issue 2, p650 

    Discusses diabetes and the use of insulin. Definition of insulin; Why a diabetic needs insulin; Need to monitor blood sugar level; Frequency of taking insulin; Time to take insulin; Information on insulin lispro; How to administer insulin; Parts of the body where to inject insulin; Insulin...

  • Flexible Insulin Regimens for People with Type 1 Diabetes.  // American Family Physician;11/15/1999, Vol. 60 Issue 8, special section p1 

    Deals with the proper use of insulin for people with type 1 diabetes. Definition of insulin; Information on the flexible insulin regimen; Importance of counting carbohydrates.

  • Insulin Administration.  // Diabetes Care;Jan2000 Supplement 1, Vol. 23, pS86 

    Addresses issues regarding the use of conventional insulin administration in the self-care of the individual with diabetes. Availability, names and properties of insulin; Storage of insulin; Administration of insulin.

  • Premixed Formulations of Insulin Lispro. Rave, Klaus; Heinemann, Lutz; Puhl, Lothar; Gudat, Uwe; Woodworth, James R.; Weyer, Christian; Heise, Tim // Diabetes Care;May99, Vol. 22 Issue 5, p865 

    Presents information on a study which determined the activity profiles of premixed formulations of insulin lispro and NPH insulin in patients with type one diabetes. Ratios of insulin lispro and its comparison with NPH insulin; Research design and methodology; Conclusions.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics